Combination therapy strategy for cancer based on RNA polymerase I inhibition

摘要

A composition comprising a combination of at least one Pol I inhibitor and at least one autophagy inhibitor compound and / or at least one ACAT1 inhibitor compound and / or at least one PARP inhibitor compound, and cancer And their use in the treatment of related neoplastic diseases, which may include additional chemotherapeutic agents.